https://www.marketscreener.com/quote/stock/CNBX-PHARMACEUTICALS-INC-120793400/news/CNBX-to-Enter-the-Cancer-Immunotherapy-Market-After-Acquiring-a-Controlling-Interest-in-TaGeza-Bioph-42242187/?utm_source=telegram&utm_medium=social&utm_campaign=share